Business Description
Sinil Pharmaceutical Co Ltd
SIC : 111
ISIN : KR7012790002
Compare
Compare
Traded in other countries / regions
012790.Korea IPO Date
1999-08-13Description
Sinil Pharmaceutical Co Ltd is a South Korean drug manufacturing company. The products of the company include diphene gel, tour pen plasta, oriental herb tea cold liquid, and griffen ssung.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.87 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.67 | |||||
| Beneish M-Score | -3.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 17.3 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year FCF Growth Rate | -4.8 | |||||
| 3-Year Book Growth Rate | 6.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.18 | |||||
| 9-Day RSI | 52.14 | |||||
| 14-Day RSI | 51.5 | |||||
| 6-1 Month Momentum % | -4.92 | |||||
| 12-1 Month Momentum % | -15.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.29 | |||||
| Quick Ratio | 4.29 | |||||
| Days Inventory | 162.47 | |||||
| Days Sales Outstanding | 90.43 | |||||
| Days Payable | 44.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.38 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 23.3 | |||||
| Forward Dividend Yield % | 2.38 | |||||
| 5-Year Yield-on-Cost % | 3.31 | |||||
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 2.24 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.72 | |||||
| Operating Margin % | 22.19 | |||||
| Net Margin % | 15 | |||||
| FCF Margin % | 2.48 | |||||
| ROE % | 10.29 | |||||
| ROA % | 8.98 | |||||
| ROIC % | 14.79 | |||||
| ROC (Joel Greenblatt) % | 31.13 | |||||
| ROCE % | 15.83 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.12 | |||||
| PE Ratio without NRI | 6.12 | |||||
| Shiller PE Ratio | 8.22 | |||||
| Price-to-Owner-Earnings | 14.79 | |||||
| PEG Ratio | 0.4 | |||||
| PS Ratio | 0.91 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| Price-to-Free-Cash-Flow | 36.88 | |||||
| Price-to-Operating-Cash-Flow | 5.45 | |||||
| EV-to-EBIT | 2.8 | |||||
| EV-to-EBITDA | 2.8 | |||||
| EV-to-Revenue | 0.66 | |||||
| EV-to-FCF | 26.6 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.4 | |||||
| Price-to-Graham-Number | 0.41 | |||||
| Price-to-Net-Current-Asset-Value | 1.62 | |||||
| Earnings Yield (Greenblatt) % | 35.76 | |||||
| FCF Yield % | 2.7 | |||||
| Forward Rate of Return (Yacktman) % | 20.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinil Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 90,063.53 | ||
| EPS (TTM) (â‚©) | 1168.84 | ||
| Beta | 1.17 | ||
| Volatility % | 22.95 | ||
| 14-Day RSI | 51.5 | ||
| 14-Day ATR (â‚©) | 161.706586 | ||
| 20-Day SMA (â‚©) | 7092 | ||
| 12-1 Month Momentum % | -15.14 | ||
| 52-Week Range (â‚©) | 6280 - 8380 | ||
| Shares Outstanding (Mil) | 11.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinil Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinil Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinil Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinil Pharmaceutical Co Ltd(XKRX:012790)'s stock price today?
The current price of XKRX:012790 is â‚©7150.00. The 52 week high of XKRX:012790 is â‚©8380.00 and 52 week low is â‚©6280.00.
When is next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790)?
The next earnings date of Sinil Pharmaceutical Co Ltd(XKRX:012790) is .
Does Sinil Pharmaceutical Co Ltd(XKRX:012790) pay dividends? If so, how much?
The Dividend Yield %  of Sinil Pharmaceutical Co Ltd(XKRX:012790) is 2.38% (As of Today), Highest Dividend Payout Ratio of Sinil Pharmaceutical Co Ltd(XKRX:012790) was 0.26. The lowest was 0.08. And the median was 0.13. The  Forward Dividend Yield % of Sinil Pharmaceutical Co Ltd(XKRX:012790) is 2.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers